Systemic Lupus Erythematosus in Hemodialysis: Survival Comparison and Mortality-Related Factors

<i>Background and Objectives</i>: We aimed to evaluate the outcome of systemic lupus erythematosus (SLE) patients undergoing hemodialysis (HD) by comparing the survival among HD patients with SLE, diabetes mellitus (DM), or other diseases in the Korean population. We also analyzed the fa...

Full description

Saved in:
Bibliographic Details
Main Authors: Hwajeong Lee, Seok-Hui Kang
Format: Article
Language:English
Published: MDPI AG 2025-01-01
Series:Medicina
Subjects:
Online Access:https://www.mdpi.com/1648-9144/61/1/155
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832588005136662528
author Hwajeong Lee
Seok-Hui Kang
author_facet Hwajeong Lee
Seok-Hui Kang
author_sort Hwajeong Lee
collection DOAJ
description <i>Background and Objectives</i>: We aimed to evaluate the outcome of systemic lupus erythematosus (SLE) patients undergoing hemodialysis (HD) by comparing the survival among HD patients with SLE, diabetes mellitus (DM), or other diseases in the Korean population. We also analyzed the factors affecting the survival of SLE patients undergoing HD. <i>Materials and Methods</i>: This retrospective study analyzed laboratory data from a national HD quality assessment program and claims data. The programs included maintenance HD patients aged ≥18 years. The patients were divided into three groups according to underlying comorbidities as follows: SLE (<i>n</i> = 569), DM (<i>n</i> = 24,665), and others (<i>n</i> = 31,004). <i>Results</i>: The Kaplan–Meier curve showed that the SLE group had better survival than the other two groups. Multivariate analysis showed that the hazard ratios were 0.89 (<i>p</i> = 0.334) in the others group and 1.32 (<i>p</i> = 0.015) in the DM group compared to those in the SLE group. In the SLE group, age, the Charlson Comorbidity Index (CCI) score, hemoglobin, serum creatinine levels, and systolic blood pressure (SBP) were associated with patient survival. <i>Conclusions</i>: This study showed that HD patients with SLE had better patient survival than those with DM and comparable survival with those with other diseases, except SLE or DM. In addition, age, CCI score, hemoglobin, serum creatinine level, and SBP were associated with survival in HD patients with SLE.
format Article
id doaj-art-8f795832dc40456c87d9aace11724be1
institution Kabale University
issn 1010-660X
1648-9144
language English
publishDate 2025-01-01
publisher MDPI AG
record_format Article
series Medicina
spelling doaj-art-8f795832dc40456c87d9aace11724be12025-01-24T13:40:53ZengMDPI AGMedicina1010-660X1648-91442025-01-0161115510.3390/medicina61010155Systemic Lupus Erythematosus in Hemodialysis: Survival Comparison and Mortality-Related FactorsHwajeong Lee0Seok-Hui Kang1Division of Rheumatology, Department of Internal Medicine, Daegu Catholic University School of Medicine, Daegu 42472, Republic of KoreaDivision of Nephrology, Department of Internal Medicine, College of Medicine, Yeungnam University, Daegu 42415, Republic of Korea<i>Background and Objectives</i>: We aimed to evaluate the outcome of systemic lupus erythematosus (SLE) patients undergoing hemodialysis (HD) by comparing the survival among HD patients with SLE, diabetes mellitus (DM), or other diseases in the Korean population. We also analyzed the factors affecting the survival of SLE patients undergoing HD. <i>Materials and Methods</i>: This retrospective study analyzed laboratory data from a national HD quality assessment program and claims data. The programs included maintenance HD patients aged ≥18 years. The patients were divided into three groups according to underlying comorbidities as follows: SLE (<i>n</i> = 569), DM (<i>n</i> = 24,665), and others (<i>n</i> = 31,004). <i>Results</i>: The Kaplan–Meier curve showed that the SLE group had better survival than the other two groups. Multivariate analysis showed that the hazard ratios were 0.89 (<i>p</i> = 0.334) in the others group and 1.32 (<i>p</i> = 0.015) in the DM group compared to those in the SLE group. In the SLE group, age, the Charlson Comorbidity Index (CCI) score, hemoglobin, serum creatinine levels, and systolic blood pressure (SBP) were associated with patient survival. <i>Conclusions</i>: This study showed that HD patients with SLE had better patient survival than those with DM and comparable survival with those with other diseases, except SLE or DM. In addition, age, CCI score, hemoglobin, serum creatinine level, and SBP were associated with survival in HD patients with SLE.https://www.mdpi.com/1648-9144/61/1/155systemic lupus erythematosushemodialysismortality
spellingShingle Hwajeong Lee
Seok-Hui Kang
Systemic Lupus Erythematosus in Hemodialysis: Survival Comparison and Mortality-Related Factors
Medicina
systemic lupus erythematosus
hemodialysis
mortality
title Systemic Lupus Erythematosus in Hemodialysis: Survival Comparison and Mortality-Related Factors
title_full Systemic Lupus Erythematosus in Hemodialysis: Survival Comparison and Mortality-Related Factors
title_fullStr Systemic Lupus Erythematosus in Hemodialysis: Survival Comparison and Mortality-Related Factors
title_full_unstemmed Systemic Lupus Erythematosus in Hemodialysis: Survival Comparison and Mortality-Related Factors
title_short Systemic Lupus Erythematosus in Hemodialysis: Survival Comparison and Mortality-Related Factors
title_sort systemic lupus erythematosus in hemodialysis survival comparison and mortality related factors
topic systemic lupus erythematosus
hemodialysis
mortality
url https://www.mdpi.com/1648-9144/61/1/155
work_keys_str_mv AT hwajeonglee systemiclupuserythematosusinhemodialysissurvivalcomparisonandmortalityrelatedfactors
AT seokhuikang systemiclupuserythematosusinhemodialysissurvivalcomparisonandmortalityrelatedfactors